In this episode, Eric Hardter and guest Kelsey Lenoch discuss recent US FDA developments, including leadership changes at CBER and CDER, staffing impacts on orphan product reviews, and the new Rare Disease Evidence Principles aimed at accelerating approvals for rare and ultra-rare conditions.They also explore evolving trial endpoints in oncology (including surrogate measures and ctDNA), transparency moves such as the public release of Complete Response Letters and the industry’s reactions, updates

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Binodh DeSilva, Senior Vice President of Bioanalysis at Ultragenyx Pharmaceutical, to explore the science and soul behind rare-disease drug development.From her early days studying electrochemistry at the University of Kansas to leading cutting-edge bioanalytical programs at Ultragenyx, Dr. DeSilva shares how curiosity and community shaped her four-decade career. She discusses the profound responsibility of

It's World Anesthesia Day tomorrow! So, we invite you to take a deep breathe. Picture a relaxing scene. Maybe a beach in Tahiti, your toes in the sand, a cold drink in hand. Now imagine your favorite music playing in the background. If Dr. Alopi Patel were your anesthesiologist, that's exactly what she'd have you do while you waited for surgery. Before she puts patients under the sway of anesthesia, she likes to explain everything that will happen after they lose consciousness and lead them in

China’s emergence as a biotech superpower may have appeared to happen suddenly, but it reflected a long-term vision and policies over many years that enabled its success. As biotechnology transforms not only medicine but also industries such as food, fuel, and materials, the competition between China and the United States to shape the future bioeconomy is intensifying. We spoke to Drew Endy, associate professor of bioengineering and senior fellow of the Hoover Institution at Stanford University,

Dr. Bronner’s Cosmic Engagement Officer David Bronner joins Divergent States for a candid, nuts-and-bolts conversation about building an “All One” company culture, pushing for psychedelic policy reform, and rewiring global supply chains to be fair, transparent, and regenerative. We trace the lineage from Rainbow Gatherings to Burning Man, from hemp activism to MAPS, and from commodity brokers to farmer-first vertical integration. Co-host therapist Valerie Beltran helps press on the tradeoffs:...

FBI just handed down charges for an illegal NBA gambling ring.

Text the Show and Show some LOVE for TR! In this episode Evariel shares a detailed converstaion with Sophia The Topic: "Demiurge, What were you thinking?" Exactly Evariel, Sophia's immense energy frequency allows for instant manifestation and as she thought on what a world disconnected from Source Creator's light would look like- The Demiurge Manifested. We get details on how she had to "descend to ascend" again and how WE have roles in correcting or neutralizing the Demiurge-The ...

Podcast Summary (100 words): Join us for Sixty Years of Rocky Shore Ecology, a fascinating journey through marine science with experimental ecologist Professor Stephen Hawkins. From his first limpet studies on the Isle of Man to pioneering work on climate change, biodiversity, and eco-engineering, Prof. Hawkins reflects on the evolving story of our coasts. As former Director of the Marine Biological Association, he shares insights into keystone grazers, shifting species, and the power of lon...

In this episode of MedTech Global Insights, we demystify the International Medical Device Regulators Forum (IMDRF) framework for Software as a Medical Device (SaMD). We break down the two-dimensional matrix used to classify SaMD risk, exploring how the significance of the information and the patient's condition determine whether your software is Class I or Class IV.We move beyond theory with concrete examples, from a simple skin-care app to a high-stakes AI diagnostic tool for cancer treatment

Digital Supply Chain Resilience: Lessons from Disruption In this episode of Center of Excellence – Pharma 4.0, we explore how the pharmaceutical industry is redefining supply chain resilience in the face of unprecedented global disruptions. From the COVID-19 pandemic to geopolitical tensions and climate-related challenges, the episode highlights how digital transformation has become the cornerstone of operational continuity and strategic strength. Join us as we unpack key lessons from recent

In this series, PathPod gathers pathologists and trainees Around The Scope to discuss their work in depth.Today, we hear about prostate pathology and how optimization of Gleason grading can improve prognostic information. Our hosts, Dr. Mike Arnold (@MArnold_PedPath) and Dr. Andrew Bellizzi (@IHC_guy) talk with Dr. Jesse McKenney, Dr. Jane Nguyen (@janenguyen44) and Dr. Sean Williamson (@Williamson_SR) of the Cleveland Clinic. Hear about how PSA screening changed the biopsies that pathologists see,

Genetic counsellors Matt and Sandra explore Huntington disease, prenatal and lab-based testing ethics, and how lab genetic counsellors act as gatekeepers. They discuss exclusion testing, the challenges of writing clear lab reports, and recent advances in gene therapy.The episode also covers the growing role of AI and automation in genetic labs, the evolving responsibilities of lab GCs, and how testing impacts life choices like career planning and family decisions.

This week, please join author Torbjørn Omland, as he discusses the article "Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial." For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20251020.442597

As October begins to switch into November, you are really seeing this month if you are living the DRAMA of Thailand or the PEACE of Bliss. In Thailand, you have a ticket to the circus & you are listening to the voice that is trying to control & stop you vs the voice that is YOU that is going to guide you to command your robot and really make the choices to live your DREAM LIFE. All timelines are meeting each other as we move into 2026 and the life you came for in BLISS is ACTUALLY here now

A beautiful activation for you to allow yourself to see yourself as the flower commanding the robot. To feel yourself as the rainbow of light vs the robot that tries to run your life.

Today Razib talks to Eric Kaufmann, a Canadian professor of politics at the University of Buckingham, where he directs the Centre for Heterodox Social Science. He earned his BA from the University of Western Ontario and his MA and PhD from the London School of Economics. Prior to his current role, he held positions at the University of Southampton and Birkbeck, University of London, which he left in October 2023. He is the author of several books, including Whiteshift: Immigration, Populism and the

He walks us through exon 44 and 45 programs, which will both likely have clinical readouts in 2026. Meanwhile, a $350M cash position gives Entrada the ability to think beyond neuromuscular conditions in the future as well.

In this episode of the General Thoracic Surgical Podcast, Dr. Linda Martin and Dr. Rishi Reddy explore the rapidly evolving landscape of lung nodule localization—a critical topic as thoracic surgeons increasingly encounter smaller, non-palpable nodules due to expanded screening and imaging practices. The conversation covers the full spectrum of localization techniques—from traditional wire and dye marking to advanced robotic bronchoscopy, ICG (indocyanine green) fluorescence, and molecular imaging

Fall is officially here, which means that the peak of cold and flu season is right around the corner. As adults, it could be a challenging time, it’s even more of a challenging time for children when it comes to airborne viruses. Joining us for a conversation about RSV today is Zach Reiser.